Related Experiment Video
Updated: Aug 16, 2025

12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
21.4K
[Protein CD133 as a tumor stem cell marker].
F I Grabovenko1, O V Kisil2, G V Pavlova3,4,5
1Lomonosov Moscow State University, Moscow, Russia.
Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko
|December 19, 2022
Summary
The CD133 protein, a transmembrane glycoprotein, is linked to cancer development. Research suggests CD133 may predict survival in solid tumors and serve as a glioma marker.
Area of Science:
- Cellular biology
- Oncology
- Biochemistry
Background:
- The CD133 protein is a large transmembrane glycoprotein with an incompletely understood cellular function.
- Despite its unclear role, CD133 is associated with neoplastic transformation and cancer progression.
- This review focuses on CD133's structure, expression, interactions, and presence in malignant cells.
Approach:
- Comprehensive literature review of existing data on the CD133 protein.
- Analysis of CD133's structure, gene expression regulation, and molecular interactions.
- Examination of CD133's representation in various malignant cell types.
Key Points:
- CD133 protein's structure and expression regulation are crucial for understanding its function.
- Molecular interactions of CD133 provide insights into its role in cell signaling and transformation.
- CD133 is frequently found in cells that have undergone malignant transformation.
Conclusions:
- CD133 protein shows significant potential as a prognostic biomarker for survival in diverse solid tumors.
- CD133 may serve as a valuable diagnostic marker, particularly for glioma.
- Further research into CD133's functions could lead to novel cancer therapies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
3.6K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K

